![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_db4ac60c18b24b7bd003d4edf05f0d21.svg) | Naloxone | IC50 | 9.0 [1], 127.0 [2] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_63a607c7e7aae8221354f9a2188414df.svg) | Naltrexone | IC50 | 2.6 [1], 12.0 [2] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_787191644827dd60f4c9cd5d3056d77d.svg) | trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide | IC50 | 5.0 [1], 3100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_c1367d9ccaaa4f7766c7ca4c78d644a9.svg) | Levallorphan | IC50 | 0.67 [1], 2.6 [2] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_7c92eac5ec3fdacf9cb402b6bc9bbc95.svg) | Cyprodime | IC50 | 170.0 [1], 628.0 [2] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_41a1b0b5bb7504b06f1c94b8c8c3b7b3.svg) | N-[(4R,4As,7S,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]acetamide | IC50 | 66.8 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_fdc9949c69261877c445326f7ca609c4.svg) | N,N'-Bis[(4R,4aS,7S,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]butanediamide | IC50 | 30.2 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_3009836c7e627f9f85771dba4dcffd46.svg) | N,N'-Bis[2-[[2-[[2-[[(4R,4aS,7S,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]butanediamide | IC50 | 25.1 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_cda7c2803e1c9b1eb8bf7faa8004c2a0.svg) | N,N'-Bis[2-[[2-[[(4R,4aS,7S,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]butanediamide | IC50 | 3.9 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_27cf835e902346aea3c2c84514e75062.svg) | N,N'-Bis[2-[[(4R,4aS,7S,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethyl]butanediamide | IC50 | 22.0 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_5a428604e817a79c9c12465a38eb3b8a.svg) | N,N'-Bis[(4R,4aR,7R,7aS,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]butanediamide | IC50 | 15.7 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_61984ca6ca674e8e7d6624d317200b7c.svg) | N,N'-Bis[2-[[(4R,4aR,7R,7aS,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethyl]butanediamide | IC50 | 19.2 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_a836cd3477be8cbc6082db7ebe99c196.svg) | N,N'-Bis[2-[[2-[[(4R,4aR,7R,7aS,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]butanediamide | IC50 | 6.3 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_5db625610bbfcdfeba47d1ec4a2f92dc.svg) | N-[(4R,4As,7R,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]acetamide | IC50 | 45.9 [1] |
![](https://images.aatbio.com/dataset/ic50/opioid-receptors-mu-kappa_ae361e41c6423bbfd66016215f58d1ac.svg) | N,N'-Bis[2-[[2-[[2-[[(4R,4aR,7R,7aS,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]butanediamide | IC50 | 12.6 [1] |